Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity-Reference-Cited by-同舟云学术

Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Published:2022-12 Issue:6 Volume:44 Page:755-761
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Hoge Rien H. L.,Detert Oude Weme Suzan E. H.,Vervenne Walter L.,van Berlo-van de Laar Inge R. F.,van Herpen Carla M. L.,Roorda Laurens,Mathôt Ron A. A.,Jacobs Maartje S.,van Erp Nielka P.,Jansman Frank G. A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Dosing strategies for anticancer drugs: the good, the bad and body-surface area;Felici;Eur J Cancer,2002

2. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area;Kaestner;Clin Oncol (R Coll Radiol).,2007

3. Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001;Baker;J Natl Cancer Inst.,2002

4. Therapeutic drug monitoring for the individualization of docetaxel dosing: a randomized pharmacokinetic study;Engels;Clin Cancer Res.,2011

5. Body composition as an independent determinant of 5-fluorouracil–based chemotherapy toxicity;Prado;Clin Cancer Res.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting on patient’s body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review;Breast Cancer Research;2024-05-22

2. Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity;Cancer Chemotherapy and Pharmacology;2024-05-11

3. Body composition and chemotherapy toxicities in breast cancer: a systematic review of the literature;Journal of Cancer Survivorship;2024-01-11